Zapatero International Limited Pharmaceutical Import Profile — Mauritius (DGFT 2022–2026)

Name: Zapatero International Limited Pharmaceutical Import Records from India — 5 Products, $1.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Zapatero International Limited — Pharmaceutical Importer Profile (2026) | 5 Products, $1.1M Trade | TransData Nexus

Zapatero International Limited

Pharmaceutical Importer · Mauritius · Advanced Diabetes Medications Focus · $1.1M Total Trade · DGFT Verified

Zapatero International Limited is a pharmaceutical importer based in Mauritius with a total trade value of $1.1M across 5 products in 2 therapeutic categories. Based on 254 verified import shipments from Indian Customs (DGFT) records, Zapatero International Limited is the #1 buyer in 1 product including Semaglutide. Zapatero International Limited sources from 1 verified Indian supplier, with Pleasant Exports accounting for 100.0% of imports.

Zapatero International Limited — Import Portfolio & Supplier Network

Zapatero International Limited import network — 5 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Zapatero International Limited?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Pleasant Exports	$871.2K	446	100.0%

Zapatero International Limited sources from 1 verified Indian supplier across 325 distinct formulations. The sourcing is highly concentrated — Pleasant Exports accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Zapatero International Limited Import?

Formulation	Value	Ships
Rybelsus 14 TAB (semaglutide/14MG	$57.9K	3
Rybelsus 14 TAB semaglutide 14 MG	$40.9K	6
Rybelsus 3 TAB semaglutide/3MG	$31.3K	2
Modula TAB tadalafil 5 MG	$21.9K	3
Rybelsus 7 TAB semaglutide 7 MG	$19.8K	4
Rybelsus TAB semaglutide/14MG	$19.7K	1
Rybelsus 7 TAB (semaglutide/7MG)	$17.1K	1
Rybelsus 14 TAB semaglutide/14MG	$16.3K	1
Mesacol od TAB mesalamine 1200MG	$16.3K	1
Restasis eye drops	$15.4K	2
Mirago 50 TAB mirabegron 50 MG	$14.0K	3
Rifagut TAB rifaximin 550 MG	$13.8K	4
Rybelsus 3 TAB	$12.7K	2
Eliquis 5 TAB apixaban 5 MG	$12.4K	2
Rybelsus 7 TAB semaglutide/7MG	$12.4K	4

Import Portfolio — Top 5 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Semaglutide	Advanced Diabetes Medications	$774.6K	85	10.8%	1
2	Empagliflozin	Diabetes & Endocrine	$193.1K	100	2.9%	5
3	Canagliflozin	Advanced Diabetes Medications	$56.0K	25	5.0%	7
4	Linagliptin	Advanced Diabetes Medications	$24.8K	35	0.6%	12
5	Saxagliptin	Advanced Diabetes Medications	$4.0K	9	0.1%	11

Zapatero International Limited imports 5 pharmaceutical products across 2 categories into Mauritius totaling $1.1M. The company is the #1 buyer for 1 product: Semaglutide.

Zapatero International Limited — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Zapatero International Limited is a pharmaceutical importer and buyer based in Mauritius, specializing in the acquisition of finished pharmaceutical formulations. The company plays a pivotal role in the distribution of pharmaceutical products within the Mauritian market, ensuring the availability of essential medications to both public and private healthcare institutions. While specific details about its parent company are not publicly disclosed, Zapatero International Limited's operations are integral to the pharmaceutical supply chain in Mauritius.

2Distribution Network

The company operates from Freeport Zone 5, Mer Rouge, Port Louis, 11609, Republic of Mauritius. This strategic location facilitates efficient logistics and distribution across the island. While specific warehouse locations and logistics capabilities are not detailed, the company's significant import volume and the central location suggest a well-established distribution network capable of meeting the demands of the Mauritian pharmaceutical market.

3Industry Role

Zapatero International Limited functions primarily as a pharmaceutical wholesaler in Mauritius. By importing a diverse range of finished pharmaceutical formulations, the company supplies these products to various stakeholders, including retail pharmacies, hospitals, and clinics. This role is crucial in ensuring the consistent availability of medications throughout the country, thereby supporting the healthcare system's efficacy.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Zapatero International Limited

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

The company's sourcing strategy exhibits a high degree of concentration, with a total import value of $1.1 million USD from India, accounting for 100% of its pharmaceutical imports. This single-source dependency indicates a strategic choice to leverage India's robust pharmaceutical manufacturing capabilities. The stability of this relationship is evidenced by 254 shipments from a single supplier, PLEASANT EXPORTS, suggesting a reliable and consistent supply chain. However, this concentration also presents a potential risk; any disruptions in India's pharmaceutical production or export policies could directly impact Zapatero International Limited's operations.

2Supply Chain Resilience

Zapatero International Limited's supply chain resilience is closely tied to its exclusive reliance on Indian suppliers, particularly PLEASANT EXPORTS. The absence of backup suppliers and the limited diversity in imported formulations may pose challenges in the event of supply chain disruptions. Additionally, the company's dependence on a single shipping route from India to Mauritius exposes it to potential logistical bottlenecks or geopolitical issues. Ensuring the regulatory compliance of key suppliers, such as PLEASANT EXPORTS, is essential to maintain uninterrupted supply and adhere to Mauritius's stringent pharmaceutical import regulations.

Importing Pharmaceuticals into Mauritius — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Mauritius

1Regulatory Authority & Framework

The primary regulatory body overseeing pharmaceutical imports in Mauritius is the Pharmacy Board, operating under the Ministry of Health and Wellness. The governing legislation includes the Pharmacy Act 1983 and the Consumer Protection (Price and Supplies Control) Act of 1998. These laws establish the framework for the authorization, marketing, sale, and supply of pharmaceutical products in the country. The Pharmacy Act defines "pharmaceutical product" as a drug, medicine, preparation, poison, or therapeutic substance, and outlines the procedures for their registration and importation.

2Import Licensing & GMP

Importers of pharmaceutical products in Mauritius must obtain a clearance from the Registrar, as stipulated in Section 25A of the Pharmacy Act. This process involves submitting an application through the TradeNet system, accompanied by a pro forma invoice and other relevant documents. The Registrar reviews the application and, upon approval, grants clearance for the importation of the pharmaceutical products. Additionally, importers are required to ensure that the pharmaceutical products are registered with the Pharmacy Board and that the manufacturing facilities hold valid Good Manufacturing Practice (GMP) certifications recognized by the World Health Organization (WHO) or the Pharmaceutical Inspection Co-operation Scheme (PIC/S).

Zapatero International Limited — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Zapatero International Limited's focus on advanced diabetes medications, particularly Semaglutide, reflects a strategic alignment with the growing demand for effective diabetes treatments in Mauritius. The substantial import value of Semaglutide ($775K) indicates a strong market presence and a commitment to providing high-quality therapeutic options. The inclusion of other antidiabetic agents like Empagliflozin, Canagliflozin, Linagliptin, and Saxagliptin in their portfolio suggests a comprehensive approach to addressing various patient needs within the diabetes care segment.

2Sourcing Profile

Zapatero International Limited's sourcing strategy is heavily reliant on Indian manufacturers, with PLEASANT EXPORTS being the sole supplier. This approach allows for streamlined procurement processes and potential cost advantages. The focus on finished pharmaceutical formulations, rather than raw Active Pharmaceutical Ingredients (APIs), indicates a preference for ready-to-market products that meet the regulatory standards of Mauritius.

3Market Positioning

By importing a specialized range of advanced diabetes medications, Zapatero International Limited positions itself as a key supplier in the Mauritian pharmaceutical market, particularly in the diabetes care segment. This strategic focus enables the company to cater to the needs of healthcare providers and patients seeking effective and reliable antidiabetic treatments.

Seller's Guide — How to Become a Supplier to Zapatero International Limited

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

The concentrated sourcing pattern of Zapatero International Limited presents an opportunity for new Indian suppliers to enter the market by offering complementary products or by ensuring consistent quality and supply reliability. Diversifying the supplier base could enhance the company's resilience and mitigate risks associated with single-source dependency.

2Requirements & Qualifications

Indian exporters aiming to supply pharmaceutical products to Zapatero International Limited must ensure that their manufacturing facilities hold valid GMP certifications recognized by WHO or PIC/S. Products must be registered with the Pharmacy Board of Mauritius, and all importation processes must comply with the regulations outlined in the Pharmacy Act and related legislation. Additionally, adherence to the Consumer Protection (Pharmaceutical Products) (Maximum Mark-Up) Regulations 2023 is mandatory.

3How to Approach

Indian exporters should initiate contact with Zapatero International Limited by presenting their product portfolios, emphasizing compliance with international quality standards and the regulatory requirements of Mauritius. Participating in relevant trade fairs and industry events in Mauritius can facilitate relationship-building. Understanding the import licensing procedures and ensuring timely regulatory filings will be crucial. Establishing a clear timeline for product registration and importation, in line with the Pharmacy Act and other relevant regulations, will enhance the likelihood of successful market entry.

Frequently Asked Questions — Zapatero International Limited

What products does Zapatero International Limited import from India?

Zapatero International Limited imports 5 pharmaceutical products across 2 categories. Top imports: Semaglutide ($774.6K), Empagliflozin ($193.1K), Canagliflozin ($56.0K), Linagliptin ($24.8K), Saxagliptin ($4.0K).

Who supplies pharmaceuticals to Zapatero International Limited from India?

Zapatero International Limited sources from 1 verified Indian suppliers. The primary supplier is Pleasant Exports (100.0% of imports, $871.2K).

What is Zapatero International Limited's total pharmaceutical import value?

Zapatero International Limited's total pharmaceutical import value from India is $1.1M, based on 254 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Zapatero International Limited focus on?

Zapatero International Limited imports across 2 categories. The largest: Advanced Diabetes Medications (81.7%), Diabetes & Endocrine (18.3%).

Get Full Zapatero International Limited Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.